GeoVax Labs, Inc. (GOVX-OTC) Nominated for 2019 ViE Awards in Three categories
GeoVax announced that it has been nominated for the 2019 ViE (Vaccine Industry Excellence) Awards in three ...
GeoVax Labs, Inc. (GOVX-OTC) Nominated for Buzz of BIO Contest - Please VOTE!!
GeoVax announced that it has been nominated in the Public Company category at the Buzz of BIO Contest, ...
November 2018 Update Issued on GeoVax Labs (GOVX-OTC)
Crystal Research Associates has released a 17-page Quarterly Update on clinical-stage biotechnology company, ...
GeoVax Labs, Inc. (GOVX-OTC) Announces Publication of HIV Vaccines Review
GeoVax Labs, Inc. announced today the publication of a manuscript entitled “HIV/AIDS Vaccines: 2018,” ...
GeoVax Labs, Inc. (GOVX-OTC) Reports Vaccine Development Progress
GeoVax Labs announced today that its Chief Scientific Officer, Dr. Farshad Guirakhoo, will deliver a talk ...
GeoVax Labs. (GOVX-OTC) Reports Promising Results for Lassa Fever Vaccine
Promising Results Reported for GeoVax's Lassa Fever Vaccine GeoVax announced today a significant step forward ...